Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Proteomics Market Size, Share, Outlook, and Analysis and Forecast 2018 – 2026

Author: Abhijit Ranjane
by Abhijit Ranjane
Posted: Mar 03, 2019

Proteomics is a study of large scale proteomes. Proteomes are entire complements of protein expressed by a tissue, cell or organism. Proteomics aims to interpret the roles of large number of proteins made from combining 22 genetically-encoded amino acids. It helps to understand the structure, function, and interactions of the entire protein content in a specific organism. It is used to investigate protein expression, rates of protein production, degradation, modification of protein, protein movements in subcellular compartments, and protein-protein interaction.

Key players in the market are focused on introducing new and improved proteomics techniques, which is expected to boost the proteomics market growth. For instance, in September 2017, Bruker Corporation launched timsTOF Pro system for parallel accumulation and serial fragmentation (PASEF) mass spectrometry— using proprietary trapped ion mobility spectrometry (TIMS) technology—to offer efficient data acquisition speed for shotgun proteomics.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2493

Moreover, in October 2018, Bruker Corporation introduced a next-generation workflow for the timsTOF Pro mass spectrometer at Human Proteome Organization (HUPO). The platform for timsTOF Pro workflow includes large-scale, reproducible, and accurate collision cross section (ccs) values for tryptic peptides, fastpro, and ccs-based lipidomics workflow.

Moreover, in 2017, Diagenode, a provider of complete solutions for epigenetics research and sample preparation, in collaboration with PreOmics GmbH, developer and provider of innovative tools for MS-based proteomics, launched new streamlined sample preparation solution for proteomic analyses. The new solution was developed by combining PreOmics in-StageTip Kit (iST Kit) and the Diagenode Bioruptor sonication system to clean peptides for mass spectrometry (MS) analysis.

Increasing collaboration and partnership activities by key players in this region. For instance, in November 2018, Thermo Fisher Scientific Inc. and Symphogen entered into a two-year collaborative partnership to deliver validated platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. Under this agreement, Symphogen would have access to Thermo Fisher’s Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC-MS/MS) system with BioPharma Option for creating, testing, and validating the platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures. Moreover, Symphogen will focus on the development of automated multi-attribute method (MAM) workflows for monitoring critical quality attributes of proteins using high-resolution accurate-mass mass spectrometry in a quality control environment.

Get Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2493

Increasing government initiatives to promote research and development in proteomics, genomics, and bioinformatics is expected to propel Asia Pacific proteomics market growth during the forecast period. For instance, the 13th International Conference on Proteomics, Genomics, and Bioinformatics will be held on May 10-11, 2019 in Tokyo, Japan. The theme of the conference will be ‘Leading Edge Innovations in Life Sciences’ and the objective will be to explore the recent advancements and new methodologies that can be applied to the research to make proteomics and bioinformatics more advance. Target audience for the upcoming conference can be health professionals, researchers and scientists, management/business leaders and/or agents, government/non-government community groups or individuals, professors, psychiatrist, and therapists.

Key players operating in the global proteomics market include, Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics Inc., PerkinElmer, Inc., Biognosys Inc., Bruker, Cell Signaling Technology, Inc., Newomics, Inc., Proteome Sciences, Applied Biomics, Inc., Courtagen Life Sciences, Inc., Xcelris Genomics., Center for Genomic Sciences, and Sera Prognostics, Inc.

Click To Continue Reading On Proteomics Market

About Coherent Market Insights:

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link :https://www.coherentmarketinsights.com/phase-xs

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

About the Author

Contact US: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel : +1-206-701-6702 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Abhijit Ranjane

Abhijit Ranjane

Member since: May 31, 2017
Published articles: 363

Related Articles